about
Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseasesDefining the catalytic activity of nanoceria in the P23H-1 rat, a photoreceptor degeneration modelGeneration and biological activities of oxidized phospholipidsCats, "rats," and bats: the comparative biology of aging in the 21st centuryCurrent development in non-enzymatic lipid peroxidation products, isoprostanoids and isofuranoids, in novel biological samples.Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial)Omega-3 fatty acid oxidation products prevent vascular endothelial cell activation by coplanar polychlorinated biphenyls.Methusaleh's Zoo: how nature provides us with clues for extending human health span.A Circulating Biomarker Risk-Prediction Model Correlates with CHADS-2 Risk Score in Chronic Atrial Fibrillation.Isoprostane generation and function.The inhibitory effect of manganese on acetylcholinesterase activity enhances oxidative stress and neuroinflammation in the rat brainSystemic markers of oxidative stress in relation to metabolic syndrome componentsLC/MS/MS method for analysis of E₂ series prostaglandins and isoprostanes.Urinary Lipid Peroxidation Byproducts: Are They Relevant for Predicting Neonatal Morbidity in Preterm Infants?Strong Associations Exist among Oxidative Stress and Antioxidant Biomarkers in the Circulating, Cellular and Urinary Anatomical Compartments in Guatemalan Children from the Western Highlands.Oxidative Stress Biomarkers and Incidence of Postoperative Atrial Fibrillation in the Omega-3 Fatty Acids for Prevention of Postoperative Atrial Fibrillation (OPERA) Trial.Renin-Angiotensin Activation and Oxidative Stress in Early Heart Failure with Preserved Ejection Fraction.Activation of the Thromboxane A2 Receptor by 8-Isoprostane Inhibits the Pro-Angiogenic Effect of Vascular Endothelial Growth Factor in SclerodermaA fast one-step extraction and UPLC-MS/MS analysis for E2/D 2 series prostaglandins and isoprostanesMajor urinary metabolites of 6-keto-prostaglandin F2α in mice.Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method.Oxidative stress in hypertension: role of the kidney.Bioactive eicosanoids: role of prostaglandin F(2α) and F₂-isoprostanes in inflammation and oxidative stress related pathology.The use of oxidative stress biomarkers in live animals (in vivo) to predict meat quality deterioration postmortem (in vitro) caused by changes in muscle biochemical components.Alteration of isocitrate dehydrogenase following acute ischemic injury as a means to improve cellular energetic status in neuroadaptation.Analysis of lipid peroxidation biomarkers in extremely low gestational age neonate urines by UPLC-MS/MS.Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men.Development of a fast and simple LC-MS/MS method for measuring the F2-isoprostanes in newborns.Preterm prelabor rupture of the membranes: A disease of the fetal membranes.Development and application of a UHPLC-MS/MS metabolomics based comprehensive systemic and tissue-specific screening method for inflammatory, oxidative and nitrosative stress.A role for trypanosomatid aldo-keto reductases in methylglyoxal, prostaglandin and isoprostane metabolism
P2860
Q26822872-0BC8FAB7-45D8-4E69-8087-FE749140B7A1Q27310554-D997BEC3-FDE9-4708-B074-3D17EAAC66D1Q28389691-27698DD9-A0E8-45E3-8581-9D5081426B4FQ28742392-1FA2D250-AE1B-48FE-8E49-F77D829C11A5Q34436623-474E87CC-B65A-40C5-B49A-D97AFF6EA368Q34500520-265A15C5-4785-495C-B304-932EA6DF5B70Q34516600-9F21DB44-B5B6-49CB-B14C-96644CDFFB5DQ34614530-79FCDBA5-EDCA-49BB-95E2-9E6F80357B48Q35105438-49CA93A8-FC25-4466-86CC-5A8C1AF773E6Q35332267-A9BD1951-6784-4D0F-92C6-990B40408ADEQ35690918-894938B7-68E0-4548-8418-0B33A7493EB1Q35714287-081041AE-ADD1-4277-B191-0EAA7354AC93Q35771195-BEEED4C0-85FB-43CC-AB59-7BFF901AA4F5Q35822095-16F11DB2-42D1-4B9A-81BD-933A000046A0Q35899128-4CFD71DF-F727-470A-9C4E-1C5298E03263Q36141379-048605D5-E85B-4446-ACFB-B55014403DA0Q36172961-A478D36D-1A59-41E1-8A3F-F4CC01A6AD6FQ36289139-35FF819D-53EF-49CB-A86B-7E09EB3E3F0AQ36718279-09E4C0D0-72BC-45A1-8356-08467B160414Q36920598-25536D8D-49F5-4B96-A142-1459462DBA30Q37359777-88753EFA-572F-4745-8ADA-FA46E1702266Q37434021-8FC63889-D661-42BC-8C6E-6936278BAE3FQ37813090-D8427842-1FF3-4984-8A6B-A1720CE96A2AQ38654507-24D15D7D-1675-4DDE-84BF-F719410ACF85Q39183725-CEFAB12B-D7DB-457D-A0F2-E970FBC18A6EQ39194532-575A425E-521D-4D72-B3CC-11D0F244181AQ41740228-672A02E4-B940-40B4-BB19-7624BD65027BQ51358982-04F601B2-13C1-4B6D-A6DA-30E8739E391DQ51803137-F864C41F-334C-4081-AB8C-5ACB459AB72CQ55007448-091A19EF-247E-4B07-99DB-4D49DCFA76EFQ58694598-6E2FC1A9-4F15-43DD-849D-26596E99DC4B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Isoprostanes
@en
Isoprostanes.
@nl
type
label
Isoprostanes
@en
Isoprostanes.
@nl
prefLabel
Isoprostanes
@en
Isoprostanes.
@nl
P2860
P1476
Isoprostanes
@en
P2093
L Jackson Roberts
P2860
P304
P356
10.1194/JLR.R800037-JLR200
P478
P577
2008-10-28T00:00:00Z